Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ciprofloxacin: an overview and prospective appraisal.

× No keyword cloud information.

16 in total

1. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections.

Authors: M B al-Sibai; M A Halim; M M el-Shaker; B A Khan; S M Qadri
Journal: Antimicrob Agents Chemother Date: 1992-01 Impact factor: 5.191

2. Modeling antibiotic resistance to project future rates: quinolone resistance in Escherichia coli.

Authors: L K Durham; M Ge; A J Cuccia; J P Quinn
Journal: Eur J Clin Microbiol Infect Dis Date: 2010-01-30 Impact factor: 3.267

3. Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus.

Authors: J E Gustafson; P V Candelaria; S A Fisher; J P Goodridge; T M Lichocik; T M McWilliams; C T Price; F G O'Brien; W B Grubb
Journal: Antimicrob Agents Chemother Date: 1999-04 Impact factor: 5.191

4. Quinolones and coumarins eliminate chloroplasts from Euglena gracilis.

Authors: J Krajcovic; L Ebringer; J Polónyi
Journal: Antimicrob Agents Chemother Date: 1989-11 Impact factor: 5.191

5. 1-Cyclo-propyl-6-fluoro-7-(4-nitro-so-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid.

Authors: Tao Li; Li-Rong Tang; Qiao-Ling Zeng; Wei-Jin Chen; Biao Huang
Journal: Acta Crystallogr Sect E Struct Rep Online Date: 2009-07-31

6. Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study.

Authors: G D Fang; C Brennen; M Wagener; D Swanson; M Hilf; L Zadecky; J DeVine; V L Yu
Journal: Antimicrob Agents Chemother Date: 1991-09 Impact factor: 5.191

7. Increasing resistance of Staphylococcus aureus to ciprofloxacin.

Authors: T E Daum; D R Schaberg; M S Terpenning; W S Sottile; C A Kauffman
Journal: Antimicrob Agents Chemother Date: 1990-09 Impact factor: 5.191

8. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.

Authors: T J Louie
Journal: CMAJ Date: 1994-03-01 Impact factor: 8.262

Review 9. Bacterial resistance to fluoroquinolones: lessons to be learned.

Authors: P Ball
Journal: Infection Date: 1994 Impact factor: 3.553

Review 10. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors: D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal: Drugs Date: 1988-04 Impact factor: 9.546